Following up on the success of “Building Biotechnology” (www.BuildingBiotechnology.com), I’m in the late stages of assembling a more advanced follow-up book featuring articles from industry insiders with deep experience.
Join a dozen other industry insiders writing about topics in:
- Business Planning
- Funding
- Valuation
- Intellectual Property
- Licensing and technology transfer
- Public Relations
Further details available upon request. If [...]
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in April 2007*Drugs may be covered by more than one patent
Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
AMBIEN
Sanofi Aventis Us
zolpidem tartrate
4,382,938
APR 21,2007
AMBIEN CR
Sanofi Aventis Us
zolpidem tartrate
4,382,938
APR 21,2007
BIDIL
Nitromed
hydralazine hydrochloride; isosorbide dinitrate
4,868,179
APR 22,2007
DEPAKOTE ER
Abbott
divalproex sodium
4,913,906
APR 03,2007
ELOCON
Schering
mometasone furoate
4,808,610
APR 02,2007
GLYNASE
Pharmacia And Upjohn
glyburide
4,916,163
APR 10,2007
INSPRA
Gd Searle Llc
eplerenone
4,559,332
APR 09,2007
NEXIUM
Astrazeneca
esomeprazole magnesium
4,738,974
APR 19,2007
PHOSLO
Fresenius Medcl
calcium acetate
4,870,105
APR 07,2007
PHOSLO GELCAPS
Fresenius Medcl
calcium acetate
4,870,105
APR 07,2007
VISUDYNE
Qlt
verteporfin
4,920,143
APR 24,2007
VOLTAREN
Novartis
diclofenac sodium
4,829,088
APR 14,2007
Courtesy [...]
Genentech is investing $140mm in a new biologic manufacturing plant in Singapore. The first commercial-scale microbial fermentation plant in Singapore, and a significant International investment by US-based Genentech. This is the latest of a number of international manufacturing and R&D centers being located in Singapore, and is a sign of the growing trend of biotechnology [...]